Venus Remedies Limited (VENUSREM.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10.96B |
| Enterprise Value | 10.78B |
| P/E Ratio | 15.86 |
| PEG Ratio | 0.22 |
| Price/Sales Ratio | 2.31 |
| Price/Book Ratio | 2.74 |
| Enterprise/Revenue | 2.3 |
| Enterprise/EBITDA | 10.39 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.14 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 7.7B |
| Revenue/Share | 626.38 |
| Gross Profit | 2.68B |
| EBITDA | 1.6B |
| Net Income | 1.03B |
| Diluted EPS | 76.89 |
Balance Sheet
| Total Cash | 901.5M |
| Total Cash/Share | 67.44 |
| Total Debt | 117.4M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 3.31 |
| Book Value Per Share | 527.05 |
Price History
| 52-Week Change | 171.9 |
| 52-Week High | 2,044.3 |
| 52-Week Low | 516.5 |
| Moving Average 50 Days | 1,571.66 |
| Moving Average 200 Days | 1,325.99 |
Statistics
| Average Volume | 35,709 |
| Shares Outstanding | 13.37M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 10 |
| Trailing Annual Dividend Yield | 0.69 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
